Enable job alerts via email!
A leading company in viral vector development seeks a Continuous Improvement Officer 2 to support quality improvement initiatives within the Analytical Services Group. The role entails developing trackers, preparing KPI reports, and ensuring regulatory compliance while fostering an environment committed to operational efficiency and quality assurance.
We are currently recruiting for a Continuous Improvement Officer 2 to join the Analytical Services Group (ASG) team. The purpose of this role is to support and drive continuous improvement initiatives, develop and maintain trackers and metrics, and contribute to the enhancement of quality systems and operational efficiency.
Our Analytical Services Group supports the development of products through analytical testing to facilitate manufacturing and process development, ensuring appropriate quality controls and use of analytics.
Your responsibilities in this role would be:
We are looking for:
About Us:
OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors—the driving force behind the majority of gene therapies.
OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV), and adenoviral vectors. Our world-class capabilities span from early-stage development to commercialisation, supported by robust quality-assurance systems, analytical methods, and regulatory expertise.
What’s in it for you:
Collaborate. Contribute. Change lives.
#LI-SCM1
Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. With over 25 years of experience in viral vectors, we are pioneers in cell and gene therapy, re-engineering viruses as safe delivery vectors for genetic material. Our collaborations span top pharmaceutical and biotech companies, providing expertise from early development to commercialization, supported by robust quality systems, analytical methods, and regulatory knowledge.